
BVNKF
Healthcare · Biotechnology · $2.78B market cap
$37.260.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 21, 2026 | After the close | 4.50 | 1.50 | -66.7% |
| May 13, 2026 | After the close | — | 0.03 | — |
| Mar 12, 2026 | After the close | -4.18 | -0.59 | +85.8% |
| Nov 14, 2025 | After the close | — | 2.19 | — |
| Aug 22, 2025 | After the close | 1.90 | 0.71 | -62.7% |
| May 6, 2025 | Before the open | — | 0.40 | — |
| Mar 5, 2025 | Before the open | — | 1.40 | — |
| Nov 15, 2024 | Before the open | — | 0.13 | — |
| Aug 22, 2024 | Before the open | 1.90 | 0.48 | -74.6% |
| May 8, 2024 | Before the open | 1.90 | -1.50 | -178.9% |
| Mar 6, 2024 | Before the open | 7.80 | 11.70 | +50.0% |
| Nov 16, 2023 | Before the open | 6.43 | -4.40 | -168.4% |
| Aug 23, 2023 | Before the open | 3.95 | 7.10 | +79.7% |
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for…
| May 9, 2023 | Before the open | 2.38 | 5.10 | +114.3% |
| Mar 2, 2023 | Before the open | 3.30 | 2.20 | -33.3% |
| Nov 9, 2022 | Before the open | -0.25 | 0.20 | +180.0% |
| Aug 24, 2022 | Before the open | -3.80 | -3.40 | +10.5% |
| May 9, 2022 | Before the open | -4.70 | -3.90 | +17.0% |
| Mar 4, 2022 | Before the open | 0.45 | -1.60 | -455.6% |
| Nov 12, 2021 | Before the open | -1.15 | -1.30 | -13.0% |
| Aug 25, 2021 | Before the open | 0.95 | -2.40 | -352.6% |
| May 27, 2021 | Before the open | -1.45 | -2.20 | -51.7% |
| Jan 28, 2021 | Before the open | -3.18 | -7.30 | -129.6% |
| Nov 11, 2020 | Before the open | 0.38 | 0.50 | +31.6% |
| Aug 26, 2020 | Before the open | -1.76 | 2.20 | +225.0% |
| May 14, 2020 | Before the open | 11.30 | 12.60 | +11.5% |
| Feb 20, 2020 | Before the open | -1.27 | -1.40 | -10.2% |
| Nov 7, 2019 | Before the open | -2.84 | -3.10 | -9.2% |
| Aug 15, 2019 | Before the open | -2.46 | -3.20 | -30.1% |
| May 22, 2019 | Before the open | -2.86 | -3.10 | -8.4% |
| Mar 21, 2019 | Before the open | -0.42 | -3.14 | -647.6% |
| Nov 9, 2018 | Before the open | -2.50 | 1.00 | +140.0% |
| Aug 16, 2018 | Before the open | -4.11 | -3.40 | +17.3% |
| May 24, 2018 | Before the open | -4.41 | -5.70 | -29.3% |
| Mar 12, 2018 | Before the open | -3.72 | -5.70 | -53.2% |